Young man covering ears, shouting Rainer Elstermann / Stone / Getty Images A four-year study of more than 8,000 men between the ages of 50 to 75 who had an elevated risk for developing prostate cancer ...
CHICAGO—Dutasteride lowers the risk of prostate cancer by 23% in men with an increased risk of the malignancy, new findings show. The findings come from the four-year Reduction by Dutasteride of ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has strengthened safety warnings for finasteride and issued precautionary advice on dutasteride, following a review of evidence on the ...
Effect of inflammation on prostate cancer incidence and dutasteride efficacy in the Reduction by Dutasteride of Cancer Events (REDUCE) study. Background: PLCO is a large-scale, randomized study to ...
Two pharmacologic methods have been used to address high PSA. The oldest, administration of antibiotics, is enticing in its simplicity. However, studies have failed to show that empiric treatment can ...
DEAR DR. ROACH: I am 71 and began having urinary issues due to benign prostatic hyperplasia many years ago. I took alpha blockers (Flomax, double Flomax and tadalifil), which didn’t provide any ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results